Login / Signup

Clinical Opportunities for Germline Pharmacogenetics and Management of Drug-Drug Interactions in Patients With Advanced Solid Cancers.

Tyler ShuggReynold C LyElizabeth J RoweSantosh PhilipsMustafa A HyderMilan RadovichMarc B RosenmanVictoria M PrattJohn T CallaghanZeruesenay DestaBryan Paul SchneiderTodd C Skaar
Published in: JCO precision oncology (2022)
Our findings demonstrate numerous clinical opportunities for germline PGx and DDI management in adults with advanced cancer.
Keyphrases
  • advanced cancer
  • palliative care
  • dna repair
  • dna damage